Program - Thursday, July 5

Print
Please click on the relevant day to view the applicable detailed program.

    Thursday, July 5
Tuesday, July 3 Wednesday, July 4
HALL A
08:00-09:00
SESSION 33 | DIGITAL HEALTH AND TELEMEDICINE
 Chairperson Mark Stovsky, USA | Tom Sudow, USA
08:00-08:05


08:05-08:15


08:15-08:25


08:25-08:35


08:35-08:45


08:45-09:00
Introduction to Telemedicine and Digital Health Section
Mark Stovsky, USA

What is Telemedicine Digital Health?
Tom Sudow, USA

Big Data in Healthcare
Joseph K. Rosenblum, Israel

Blockchain in Healthcare
Shelly Hod Moyal, Israel

Artificial Intelligence in Healthcare
Talor Sax, Israel

Discussion
 
09:00-10:30
SESSION 36 | CLINICAL APPLICATIONS OF DIGITAL HEALTH
 Chairpersons  Mark Stovsky, USA | Tom Sudow, USA
09:00-09:40



09:40-10:00


10:00-10:15

10:15-10:30
Inpatient Telemedicine using the InTouch Health and PercuVision Technologies
Outpatient Telemedicine using the AmericanWell platform
Mark Stovsky, USA

Digital Health Applications in Female Urology
Howard Goldman, USA

Discussion

Digital Sex
Gila Bronner, Israel
 
10:30-11:00
Coffee Break and Poster Viewing
 
11:00-12:15
SESSION 39 | PRACTICAL ISSUES IN DIGITAL HEALTH
Chairpersons  Mark Stovsky, USA | Tom Sudow, USA
11:00-11:15


11:15-11:30


11:30-11:45


11:45-12:00


12:00-12:15
Cybersecurity and Privacy
Michael Stovsky, USA

Data Management and Security
Hovav Dror, Israel

Making Digital Health Clinically Relevant
Morris Laster, Israel

Challenges in Digital Health Innovation – Devices, Diagnostics and Therapeutics
Ophir Shahaf, Israel

Discussion
 
12:15-13:15
SESSION 42 | HONORARY GUEST SPEAKER LECTURE
 Chairperson Jacob Ramon, Israel
 
The United States and Israel Face a Changing Middle East
Daniel Shapiro, Israel
Former U.S. Ambassador to Israel
 
13:15-14:00
Lunch Break and Poster Viewing
 
14:00-15:15
SESSION 43 | PROSTATE CANCER ACTIVE SURVEILLANCE (AS)
 Chairpersons Laurence Klotz, Canada | Ilan Leibovitch, Israel
14:00-14:15


14:15-14:30


14:30-14:40


14:40-14:55



14:55-15:15
14:55-15:05
15:05-15:15
Critical role of pathology for AS criteria and definition of “Progression”
Jonathan Epstein, USA

Proper selection of patients for AS
Mitchell C. Benson, USA

AS in young men
Adam Feldman, USA

Can MRI replace biopsy in men on AS?
Yes: Arnauld Villers, France
No: Robert Reiter, USA

AS for intermediate risk Prostate Cancer
For: Larry Goldenberg, Canada
Against: Laurence Klotz, Canada 
 
15:15-16:30
SESSION 45 | CONTROVERSIAL TOPICS IN PROSTATE CANCER DIAGNOSIS
Chairperson  Arnauld Villers, France | Michael Cohen, Israel 
15:15-15:30



15:30-15:45



15:45-16:00



16:00-16:15



16:15-16:30
A PSA threshold of 1.5 ng/ml for further diagnostic tests:
For: Leonard Gomella, USA
Against: Hanan Goldberg, Canada

Negative mpMRI able to rule out significant Prostate Cancer:
Agree: Arnauld Villers, France
Disagree: Orit Raz, Israel

MRI Fusion Prostate Biopsy: The new “gold standard” for Prostate Cancer diagnosis:
Agree: Itay Sternberg, Israel
Disagree: James N'Dow, UK

Genetics and Genomics should be used prior to prostate biopsy:
Prior to 1st biopsy: Mark Stovsky, USA
Only for re-biopsy: Larry Goldenberg, Canada

A biopsy can be avoided in patients with positive DRE and negative MRI:
Agree: Arnauld Villers, France
Disagree: Michael Cohen, Israel
 
16:30-17:00
Coffee Break and Poster Viewing
 
17:00-18:30
SESSION 47 | PROSTATE CANCER: ROBOTIC SURGERY
 Chairpersons  Alexander Mottrie, Belgium | David Kakiashvilli, Israel
17:00-17:15


17:15-17:30
17:15-17:25
17:25-17:30

17:30-17:45
17:30-17:40
17:40-17:45

17:45-18:00


18:00-18:15


18:15-18:30
Lymphadenectomy in PC
Senthil Nathan, UK

The Bocciardi technique: Trans Douglas Retiuz Sparing Prostatectomy
Markus Hohenfellner, Germany
Comments: Arieh Shalhav, USA

New approaches in potency preservation in RALP
Phillip Stricker, Australia
Comments: Alexandre Mottrie, Belgium

Is the urinary sphincter at risk during dorsal vein plexus ligation?
Claude Abbou, France

The importance of maximal restoration of peri-prostatic support
Alexandre Mottrie, Belgium

The importance of full functional urethral length preservation and nerve-sparing technique on continence
Derya Tilki, Germany
 
HALL B
08:00-09:00
SESSION 34 | METASTATIC RENAL CELL CARCINOMA
 Chairpersons  Arnaud  Méjean, France | Eli Rosenbaum, Israel
08:00-08:15


08:15-08:30


08:30-08:45


08:45-09:00
If Metastasectomy is possible: Is further systemic therapy required?
Ari Hakimi, USA

The rational for Immunotherapy as first-line therapy in mRCC
Arnaud  Méjean, France

Optimizing treatment for mRCC after initial antiangiogenic therapy 
Ari Hakimi, USA

Discussion
 
09:00-10:30
SESSION 37 | CASE STUDIES ON NON-MUSCLE INVASIVE AND MUSCLE INVASIVE BLADDER CANCER
Chairpersons  Mark Soloway, USA
09:00-10:30
Case Presentations & Panel Discussion

Moderator: Mark Soloway, USA

Panelists: Jack Baniel, Israel | Amnon Zisman, Israel | Avivit Peer, Israel
Eli Rosenbaum, Israel | Vedang Murthy, India | Zvi Symon, Israel | Can Obek, Turkey
 
10:30-11:00
Coffee Break and Poster Viewing
 
11:00-12:15
SESSION 40 | PROSTATE CANCER: SURVIVOR DEBATE
Chairpersons  Laurence Klotz, Canada | Ran Katz, Israel
 11:00-11:05



11:05-11:45
11:05-11:10
11:10-11:15
11:15-11:20
11:20-11:25
11:25-11:30
11:30-11:35
11:35-11:40
11:40-11:45

11:45-11:50


11:50-12:05

12:05-12:10

12:10-12:15
Introduction
Case: Intermediate risk prostate cancer case with a 1 cm PZ lesion on MRI
What is the preferred treatment?

Round One
Robotic RP: Claude Abbou, France
Open RP: Derya Tilki, Germany
Focal HIFU: Neil Fleshner, Canada
Focal Cryo: Bernard Malavaud, France
Vascular Targeted Therapy: Jonathan Coleman, USA
External Beam Irradiation: Amichai Meirovitz, Israel
Brachytherapy: Zvi Symon, Israel
Active Surveillance: Laurence Klotz, Canada

Audience Vote

Round Two: Laurence Klotz, Canada

Audience Vote

Chairman Closure
 
12:15-13:15
SESSION 42 | HONORARY GUEST SPEAKER LECTURE (Hall A)
Chairperson
Jacob Ramon, Israel
  The United States and Israel Face a Changing Middle East
Dan Shapiro, Israel
Former U.S. Ambassador to Israel
 
13:15-14:00
Lunch Break and Poster Viewing
 
14:00-15:15
SESSION 44 | INFERTILITY AND ED
Chairpersons   Ege Serefoglu, Turkey | Yoram Vardi, Israel
14:00-14:15


14:15-14:30


14:30-14:45


14:45-15:00


15:00-15:15
A new look on sperm DNA damage
Edouard Amar, France

The Treatment of Hypogonadism in Men of Reproductive Age: A review of Non-Testosterone Therapies
Natan Bar-Chama, USA

The challenges of Hypogonadism management in Prostate Cancer patients 
Claude Schulman, Belgium

Postprostatectomy Sexual Dysfunction: Is restoring erections enough?
 
Shockwave therapy for of ED: What is the evidence in 2018:
Noam Kitrey, Israel
 
15:15-16:30
SESSION 46 | RCC COMPLEX CASES
 Chairpersons Arieh Shalhav, USA | Yoram Dekel, Israel 
15:15-15:30


15:30-15:45


15:45-15:55


15:55-16:05


16:05-16:15


16:15-16:25


16:25-16:30
Management of renal masses in Tuberous Sclerosis Complex
Adam Feldman, USA

RCC in patients with ADPKD/CKD/ESRD
David Goldfarb, USA

Nephron sparing surgery for multifocal RCC
Gennady Bratslavsky, USA

Partial Nephrectomy for difficult Stage 1 Tumors 
Arieh Shalhav, USA

Robotic Partial Nephrectomy for T1B renal tumors
Alexandre Mottrie, Belgium

Robotic Partial Nephrectomy for Hilar tumors
Claude Abbou, France

Discussion
 
16:30-17:00
Coffee Break and Poster Viewing
 
HALL C
08:00-09:00 SESSION 35 | PEDIATRIC UROLOGY: PEDIATRIC ROBOTIC SURGERY
 Chairpersons Martin Koyle, Canada | Jacob Ben Chaim, Israel
08:00-08:15


08:15-08:30


08:30-08:45


08:45-09:00
Robotic approach for upper urinary tract duplication
Paul Noh, USA

Robotic ureteral reimplantation
Amos Neheman, Israel

Infant robotic pyeloplasty
Boris Chertin, Israel

Discussion
 
09:00-10:30 SESSION 38 | PEDIATRIC UROLITHIASIS
 Chairpersons
Jonathan Glass, UK | Pinhas M. Livne, Israel
09:00-09:15


09:15-09:35
09:15-09:30
09:30-09:35

09:35-09:50


09:50-10:30
The case for a Multi-Disciplinary Pediatric Stone Center
Eugene Minevich, USA

Pediatric stone disease in the 21st century: A U.K. perspective 
Jonathan Glass, UK
Comments: Sarel Halachmi, Israel

Challenges of stone management in “Complex” patients
Eugene Minevich, USA

Case Presentations & Panel Discussion 
Moderator: Ilan Kafka, Israel

Panelists: Eugene Minevich, USA | Jonathan Glass, UK | Roy Morag, Israel
Yoram Mor, Israel | Pinhas M. Livne, Israel
 
10:30-11:00
Coffee Break and Poster Viewing
 
11:00-12:15 SESSION 41 | PEDIATRIC UROLOGY
 Chairpersons Eugene Minevich, USA | David Ben Meir, Israel
11:00-11:15


11:15-11:35
11:15-11:30
11:30-11:35

11:35-12:15
11:35-11:55
11:55-12:15
Pediatric Renal Sarcomas
Mangray Shamlal, USA

“Novel” approaches to managing the ureter-Defying Paradigms
Martin Koyle, Canada
Comments: Yoram Mor, Israel

Transition of Care of Pediatric patients
Jonathon Olsburgh, UK
Discussions and Comments: Eugene Minevich, USA